|
1
|
Wong HH and Lemoine NR: Biological
approaches to therapy of pancreatic cancer. Pancreatology.
8:431–461. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Merl MY, Chabot J and Saif MW:
Updates of adjuvant therapy in pancreatic cancer: where are we and
where are we going? In: Highlights from the ‘2010 ASCO Annual
Meeting’; Chicago, IL, USA. June 4–8, 2010; JOP. 11. pp. 310–312.
2010, PubMed/NCBI
|
|
3
|
Porchet N, Nguyen VC, Dufosse J, et al:
Molecular cloning and chromosomal localization of a novel human
tracheo-bronchial mucin cDNA containing tandemly repeated sequences
of 48 base pairs. Biochem Biophys Res Commun. 175:414–422. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moniaux N, Nollet S, Porchet N, Degand P,
Laine A and Aubert JP: Complete sequence of the human mucin MUC4: a
putative cell membrane-associated mucin. Biochem J. 338:325–333.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rachagani S, Torres MP, Moniaux N and
Batra SK: Current status of mucins in the diagnosis and therapy of
cancer. Biofactors. 35:509–527. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torres MP, Chakraborty S, Souchek J and
Batra SK: Mucin-based targeted pancreatic cancer therapy. Curr
Pharm Des. 18:2472–2481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Andrianifahanana M, Moniaux N, Schmied BM,
et al: Mucin (MUC) gene expression in human pancreatic
adenocarcinoma and chronic pancreatitis: a potential role of MUC4
as a tumor marker of diagnostic significance. Clin Cancer Res.
7:4033–4040. 2001.
|
|
8
|
Jhala N, Jhala D, Vickers SM, et al:
Biomarkers in diagnosis of pancreatic carcinoma in fine-needle
aspirates. Am J Clin Pathol. 126:572–579. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Y, Zhang JJ, Zhu R, et al: The
increase in the expression and hypomethylation of MUC4 gene with
the progression of pancreatic ductal adenocarcinoma. Med Oncol.
28(Suppl 1): S175–S184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saitou M, Goto M, Horinouchi M, et al:
MUC4 expression is a novel prognostic factor in patients with
invasive ductal carcinoma of the pancreas. J Clin Pathol.
58:845–852. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bafna S, Kaur S, Momi N and Batra SK:
Pancreatic cancer cells resistance to gemcitabine: the role of MUC4
mucin. Br J Cancer. 101:1155–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chaturvedi P, Singh AP, Moniaux N, et al:
MUC4 mucin potentiates pancreatic tumor cell proliferation,
survival, and invasive properties and interferes with its
interaction to extracellular matrix proteins. Mol Cancer Res.
5:309–320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh AP, Moniaux N, Chauhan SC, Meza JL
and Batra SK: Inhibition of MUC4 expression suppresses pancreatic
tumor cell growth and metastasis. Cancer Res. 64:622–630. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rachagani S, Macha MA, Ponnusamy MP, et
al: MUC4 potentiates invasion and metastasis of pancreatic cancer
cells through stabilization of fibroblast growth factor receptor 1.
Carcinogenesis. 33:1953–1964. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei J, Gao W, Wu J, et al: Dendritic cells
expressing a combined PADRE/MUC4-derived polyepitope DNA vaccine
induce multiple cytotoxic T-cell responses. Cancer Biother
Radiopharm. 23:121–128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Wei J, Meng K, et al: Identification
of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable
vaccine therapy. Immunopharmacol Immunotoxicol. 31:468–476.
2009.
|
|
17
|
Gao WT, Zhang JJ, Zhu Y, et al: Pentamer
guided HLA-restricted epitope identification for mucoprotein 4
antigen of pancreatic ductal adenocarcinoma. Zhonghua Wai Ke Za
Zhi. 48:1416–1424. 2010.(In Chinese).
|
|
18
|
Singh AP, Chaturvedi P and Batra SK:
Emerging roles of MUC4 in cancer: a novel target for diagnosis and
therapy. Cancer Res. 67:433–436. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hollingsworth MA and Swanson BJ: Mucins in
cancer: protection and control of the cell surface. Nat Rev Cancer.
4:45–60. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin Qin P, Su F, Xiao Yan W, et al:
Distribution of human leucocyte antigen-A, -B and -DR alleles and
haplotypes at high resolution in the population from Jiangsu
province of China. Int J Immunogenet. 38:475–481. 2011.PubMed/NCBI
|
|
21
|
Nagy P, Friedlander E, Tanner M, et al:
Decreased accessibility and lack of activation of ErbB2 in JIMT-1,
a herceptin-resistant, MUC4-expressing breast cancer cell line.
Cancer Res. 65:473–482. 2005.PubMed/NCBI
|
|
22
|
Workman HC, Sweeney C and Carraway KL III:
The membrane mucin Muc4 inhibits apoptosis induced by multiple
insults via ErbB2-dependent and ErbB2-independent mechanisms.
Cancer Res. 69:2845–2852. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moffat J, Grueneberg DA, Yang X, et al: A
lentiviral RNAi library for human and mouse genes applied to an
arrayed viral high-content screen. Cell. 124:1283–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma C, Zhang J, Durrin LK, et al: The BCL2
major breakpoint region (mbr) regulates gene expression. Oncogene.
26:2649–2657. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim GG, Donnenberg VS, Donnenberg AD,
Gooding W and Whiteside TL: A novel multiparametric flow
cytometry-based cytotoxicity assay simultaneously immunophenotypes
effector cells: comparisons to a 4 h 51Cr-release assay.
J Immunol Methods. 325:51–66. 2007. View Article : Google Scholar
|
|
26
|
Sedgwick JD, Riminton DS, Cyster JG and
Korner H: Tumor necrosis factor: a master-regulator of leukocyte
movement. Immunol Today. 21:110–113. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moss ML, Jin SL, Milla ME, et al: Cloning
of a disintegrin metalloproteinase that processes precursor
tumour-necrosis factor-α. Nature. 385:733–736. 1997.PubMed/NCBI
|
|
28
|
Wiley SR, Schooley K, Smolak PJ, et al:
Identification and characterization of a new member of the TNF
family that induces apoptosis. Immunity. 3:673–682. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pitti RM, Marsters SA, Ruppert S, Donahue
CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2
ligand, a new member of the tumor necrosis factor cytokine family.
J Biol Chem. 271:12687–12690. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Komatsu M, Yee L and Carraway KL:
Overexpression of sialomucin complex, a rat homologue of MUC4,
inhibits tumor killing by lymphokine-activated killer cells. Cancer
Res. 59:2229–2236. 1999.PubMed/NCBI
|
|
31
|
Nagata S: Apoptosis by death factor. Cell.
88:355–365. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krammer PH, Arnold R and Lavrik IN: Life
and death in peripheral T cells. Nat Rev Immunol. 7:532–542. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maher S, Toomey D, Condron C and
Bouchier-Hayes D: Activation-induced cell death: the controversial
role of Fas and Fas ligand in immune privilege and tumour
counterattack. Immunol Cell Biol. 80:131–137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rivoltini L, Carrabba M, Huber V, et al:
Immunity to cancer: attack and escape in T lymphocyte-tumor cell
interaction. Immunol Rev. 188:97–113. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Igney FH, Behrens CK and Krammer PH: CD95L
mediates tumor counterattack in vitro but induces
neutrophil-independent tumor rejection in vivo. Int J
Cancer. 113:78–87. 2005.PubMed/NCBI
|
|
36
|
Derby MA, Snyder JT, Tse R,
Alexander-Miller MA and Berzofsky JA: An abrupt and concordant
initiation of apoptosis: antigen-dependent death of CD8+
CTL. Eur J Immunol. 31:2951–2959. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khazaie K and von Boehmer H: The impact of
CD4+CD25+ Treg on tumor specific
CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol.
16:124–136. 2006.
|
|
38
|
Miyara M and Sakaguchi S: Natural
regulatory T cells: mechanisms of suppression. Trends Mol Med.
13:108–116. 2007. View Article : Google Scholar
|
|
39
|
Carraway KL, Perez A, Idris N, et al:
Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer
and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol
Biol. 71:149–185. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jepson S, Komatsu M, Haq B, et al:
Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces
specific phosphorylation of ErbB2 and enhances expression of
p27kip, but does not activate mitogen-activated kinase
or protein kinaseB/Akt pathways. Oncogene. 21:7524–7532. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chaturvedi P, Singh AP, Chakraborty S, et
al: MUC4 mucin interacts with and stabilizes the HER2 oncoprotein
in human pancreatic cancer cells. Cancer Res. 68:2065–2070. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carraway KL, Ramsauer VP, Haq B and
Carothers Carraway CA: Cell signaling through membrane mucins.
Bioessays. 25:66–71. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Carraway CA and Carraway KL: Sequestration
and segregation of receptor kinases in epithelial cells:
implications for ErbB2 oncogenesis. Sci STKE.
2007.re32007.PubMed/NCBI
|
|
44
|
Desseyn JL, Tetaert D and Gouyer V:
Architecture of the large membrane-bound mucins. Gene. 410:215–222.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Timpl R: Structure and biological activity
of basement membrane proteins. Eur J Biochem. 180:487–502. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mayer U, Kohfeldt E and Timpl R:
Structural and genetic analysis of laminin-nidogen interaction. Ann
NY Acad Sci. 857:130–142. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ciccarelli FD, Doerks T and Bork P: AMOP,
a protein module alternatively spliced in cancer cells. Trends
Biochem Sci. 27:113–115. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chaturvedi P, Singh AP and Batra SK:
Structure, evolution, and biology of the MUC4 mucin. FASEB J.
22:966–981. 2008. View Article : Google Scholar : PubMed/NCBI
|
